Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.170
-0.160 (-12.03%)
At close: Jun 18, 2026, 4:00 PM EDT
1.210
+0.040 (3.42%)
After-hours: Jun 18, 2026, 7:30 PM EDT
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $4.71 million as of June 18, 2026. Its market cap has increased by 4.21% in one year.
Market Cap
4.71M
Enterprise Value
-2.24M
1-Year Change
4.21%
Ranking
Category
Stock Price
$1.17
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $4.71M, a decrease of -91.81%. That is a compound annual growth rate of -40.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 18, 2026 | 4.71M | -23.75% |
| Dec 31, 2025 | 6.17M | 124.01% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alaunos Therapeutics | 5.21M |
| CDT Equity | 4.96M |
| Mustang Bio | 4.92M |
| CollPlant Biotechnologies | 4.86M |
| Enveric Biosciences | 4.71M |
| Alzamend Neuro | 4.64M |
| Clearmind Medicine | 4.56M |
| TransCode Therapeutics | 4.47M |